Skip to main content

Table 3 Characteristics of 30 treatment eligible children who died prior to the initiation of ART

From: Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa

Cause of death

Age at eligibility

Sex

WHO clinical stage at eligibility

CD4% or absolute CD4 count at eligibility

Place of death

Disseminated Tuberculosis, Sepsis

13 years

M

1

140 cells/mm3

Hospital

Disseminated Tuberculosis, Sepsis

8 years

M

3

10 cells/mm3

Hospital

Kaposi Sarcoma

7 years

M

4

-

Hospital

Severe Malnutrition

8 months

M

4

22%

Hospital

Severe Malnutrition, Sepsis

19 months

M

4

27%

Hospital

Severe Malnutrition, Sepsis

8 years

F

4

120 cells/mm3

Hospital

Tuberculosis

19 months

F

3

13%

Hospital

Tuberculosis

2 years

M

3

9%

Hospital

Tuberculosis

7 months

M

3

10%

Hospital

Tuberculosis

6 years

M

3

30 cells/mm3

Hospital

Tuberculosis, Meningitis

11 years

M

4

10 cells/mm3

Hospital

Very Severe Pneumonia

8 months

M

3

8%

Hospital

Unknown

2 years

F

2

3%

Home

Unknown

4 years

F

-

3%

Home

Unknown

20 months

M

4

9%

Home

Unknown

1 month

F

1

10%

Home

Unknown

13 months

F

3

19%

Home

Unknown

23 months

F

-

7%

Home

Unknown

2 years

F

4

16%

Home

Unknown

3 years

M

2

13%

Home

Unknown

19 months

F

-

8%

Home

Unknown

13 years

M

-

20 cells/mm3

Home

Unknown

14 years

M

2

320 cells/mm3 (8%)

Home

Unknown

10 years

F

1

20 cells/mm3

Home

Unknown

6 years

M

1

160 cells/mm3

Home

Unknown

10 years

M

1

10 cells/mm3

Home

Unknown

12 years

M

-

380 cells/mm3 (11%)

Home

Unknown

12 years

F

3

60 cells/mm3

Home

Unknown

6 years

M

4

540 cells/mm3

Home

Unknown

9 years

F

-

90 cells/mm3

Home